Edition:
United States

Trovagene Inc (TROV.OQ)

TROV.OQ on NASDAQ Stock Exchange Capital Market

0.65USD
26 May 2017
Change (% chg)

$-0.04 (-5.64%)
Prev Close
$0.69
Open
$0.74
Day's High
$0.74
Day's Low
$0.65
Volume
37,305
Avg. Vol
46,402
52-wk High
$5.97
52-wk Low
$0.65

TROV.OQ

Chart for TROV.OQ

About

Trovagene, Inc. (TrovaGene) is a molecular diagnostic company. The Company focuses on the development and commercialization of a molecular diagnostic technology for use in disease detection and monitoring across a range of medical disciplines. Its primary internal focus is to leverage its cell-free molecular diagnostic platform... (more)

Overall

Beta: 0.53
Market Cap(Mil.): $20.17
Shares Outstanding(Mil.): 30.97
Dividend: --
Yield (%): --

Financials

  TROV.OQ Industry Sector
P/E (TTM): -- 31.44 17.41
EPS (TTM): -1.28 -- --
ROI: -96.32 12.84 -5.42
ROE: -150.33 15.33 -4.68

BRIEF-Trovagene announces Q1 loss per share $0.32

* Trovagene announces first quarter 2017 company highlights and financial results

May 10 2017

BRIEF-Trovagene reports Q4 loss per share $0.34

* Trovagene reports fourth quarter and year end 2016 financial results

Mar 15 2017

BRIEF-Trovagene, Nerviano announce license agreement for therapeutic candidate PCM-075

* Trovagene and Nerviano announce license agreement for therapeutic candidate PCM-075

Mar 15 2017

More From Around the Web

Earnings vs. Estimates